Pre-order Enquiry
Request Free Sample
Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17294291 | Publishing Date : 29-Jan-2021 | No. of pages : 157
Detailed TOC of Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market by Application
1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bio Similars/Subsequent Entry Biologic Market Perspective (2016-2027)
2.2 Bio Similars/Subsequent Entry Biologic Growth Trends by Regions
2.2.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bio Similars/Subsequent Entry Biologic Historic Market Share by Regions (2016-2021)
2.2.3 Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Regions (2022-2027)
2.3 Bio Similars/Subsequent Entry Biologic Industry Dynamic
2.3.1 Bio Similars/Subsequent Entry Biologic Market Trends
2.3.2 Bio Similars/Subsequent Entry Biologic Market Drivers
2.3.3 Bio Similars/Subsequent Entry Biologic Market Challenges
2.3.4 Bio Similars/Subsequent Entry Biologic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue
3.1.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue (2016-2021)
3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2016-2021)
3.2 Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bio Similars/Subsequent Entry Biologic Revenue
3.4 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio
3.4.1 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Similars/Subsequent Entry Biologic Revenue in 2020
3.5 Bio Similars/Subsequent Entry Biologic Key Players Head office and Area Served
3.6 Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
3.7 Date of Enter into Bio Similars/Subsequent Entry Biologic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Similars/Subsequent Entry Biologic Breakdown Data by Type
4.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Type (2016-2021)
4.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2022-2027)
5 Bio Similars/Subsequent Entry Biologic Breakdown Data by Application
5.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Application (2016-2021)
5.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bio Similars/Subsequent Entry Biologic Market Size (2016-2027)
6.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type
6.2.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021)
6.2.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027)
6.2.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2027)
6.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Application
6.3.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021)
6.3.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027)
6.3.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2027)
6.4 North America Bio Similars/Subsequent Entry Biologic Market Size by Country
6.4.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021)
6.4.2 North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bio Similars/Subsequent Entry Biologic Market Size (2016-2027)
7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type
7.2.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021)
7.2.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027)
7.2.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2027)
7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application
7.3.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021)
7.3.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027)
7.3.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2027)
7.4 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country
7.4.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021)
7.4.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size (2016-2027)
8.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type
8.2.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2027)
8.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application
8.3.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2027)
8.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region
8.4.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size (2016-2027)
9.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type
9.2.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021)
9.2.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027)
9.2.3 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2027)
9.3 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application
9.3.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021)
9.3.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027)
9.3.3 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2027)
9.4 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country
9.4.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021)
9.4.2 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size (2016-2027)
10.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type
10.2.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2027)
10.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application
10.3.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2027)
10.4 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country
10.4.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sun Pharma
11.1.1 Sun Pharma Company Details
11.1.2 Sun Pharma Business Overview
11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Introduction
11.1.4 Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.1.5 Sun Pharma Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Introduction
11.4.4 LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Introduction
11.5.4 Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Introduction
11.6.4 Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.6.5 Hospira Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Bio Similars/Subsequent Entry Biologic Introduction
11.7.4 Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Introduction
11.8.4 Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Introduction
11.9.4 Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Introduction
11.10.4 Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Celltrion
11.11.1 Celltrion Company Details
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Introduction
11.11.4 Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.11.5 Celltrion Recent Development
11.12 Biocon
11.12.1 Biocon Company Details
11.12.2 Biocon Business Overview
11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Introduction
11.12.4 Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.12.5 Biocon Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Introduction
11.13.4 Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.13.5 Amgen Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Details
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Introduction
11.14.4 Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.14.5 Samsung Biologics Recent Development
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Introduction
11.15.4 Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.15.5 Mylan Recent Development
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Details
11.16.2 Dr. Reddy's Laboratories Business Overview
11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Introduction
11.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.16.5 Dr. Reddy's Laboratories Recent Development
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Details
11.17.2 Stada Arzneimittel AG Business Overview
11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Introduction
11.17.4 Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.17.5 Stada Arzneimittel AG Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Details
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Introduction
11.18.4 AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.18.5 AbbVie Recent Development
11.18 Sanofi-Aventis
11.25.1 Sanofi-Aventis Company Details
11.25.2 Sanofi-Aventis Business Overview
11.25.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Introduction
11.25.4 Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.25.5 Sanofi-Aventis Recent Development
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Details
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Introduction
11.20.4 Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.20.5 Johnson & Johnson Recent Development
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Details
11.21.2 Novo Nordisk Business Overview
11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Introduction
11.21.4 Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.21.5 Novo Nordisk Recent Development
11.22 Eli Lilly
11.22.1 Eli Lilly Company Details
11.22.2 Eli Lilly Business Overview
11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Introduction
11.22.4 Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.22.5 Eli Lilly Recent Development
11.23 Novartis
11.23.1 Novartis Company Details
11.23.2 Novartis Business Overview
11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Introduction
11.23.4 Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.23.5 Novartis Recent Development
11.24 3sbio
11.24.1 3sbio Company Details
11.24.2 3sbio Business Overview
11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Introduction
11.24.4 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.24.5 3sbio Recent Development
11.25 Biotech
11.25.1 Biotech Company Details
11.25.2 Biotech Business Overview
11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Introduction
11.25.4 Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.25.5 Biotech Recent Development
11.26 Gelgen
11.26.1 Gelgen Company Details
11.26.2 Gelgen Business Overview
11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Introduction
11.26.4 Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.26.5 Gelgen Recent Development
11.27 Innovent
11.27.1 Innovent Company Details
11.27.2 Innovent Business Overview
11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Introduction
11.27.4 Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.27.5 Innovent Recent Development
11.28 Dong Bao
11.28.1 Dong Bao Company Details
11.28.2 Dong Bao Business Overview
11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Introduction
11.28.4 Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.28.5 Dong Bao Recent Development
11.29 Ganlee
11.29.1 Ganlee Company Details
11.29.2 Ganlee Business Overview
11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Introduction
11.29.4 Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
11.29.5 Ganlee Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Vaccines
Table 7. Key Players of Other
Table 8. Global Bio Similars/Subsequent Entry Biologic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bio Similars/Subsequent Entry Biologic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Bio Similars/Subsequent Entry Biologic Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Bio Similars/Subsequent Entry Biologic Market Share by Regions (2016-2021)
Table 12. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Bio Similars/Subsequent Entry Biologic Market Share by Regions (2022-2027)
Table 14. Bio Similars/Subsequent Entry Biologic Market Trends
Table 15. Bio Similars/Subsequent Entry Biologic Market Drivers
Table 16. Bio Similars/Subsequent Entry Biologic Market Challenges
Table 17. Bio Similars/Subsequent Entry Biologic Market Restraints
Table 18. Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Bio Similars/Subsequent Entry Biologic Market Share by Players (2016-2021)
Table 20. Global Top Bio Similars/Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2020)
Table 21. Ranking of Global Top Bio Similars/Subsequent Entry Biologic Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Bio Similars/Subsequent Entry Biologic Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
Table 25. Date of Enter into Bio Similars/Subsequent Entry Biologic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2016-2021)
Table 29. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2016-2021)
Table 33. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country (2022-2027) & (US$ Million)
Table 65. Sun Pharma Company Details
Table 66. Sun Pharma Business Overview
Table 67. Sun Pharma Bio Similars/Subsequent Entry Biologic Product
Table 68. Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 69. Sun Pharma Recent Development
Table 70. Synthon Pharmaceuticals Company Details
Table 71. Synthon Pharmaceuticals Business Overview
Table 72. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product
Table 73. Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 74. Synthon Pharmaceuticals Recent Development
Table 75. Teva Pharmaceutical Industries Company Details
Table 76. Teva Pharmaceutical Industries Business Overview
Table 77. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product
Table 78. Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 79. Teva Pharmaceutical Industries Recent Development
Table 80. LG Life Sciences Company Details
Table 81. LG Life Sciences Business Overview
Table 82. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product
Table 83. LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 84. LG Life Sciences Recent Development
Table 85. Celltrion Biocon Company Details
Table 86. Celltrion Biocon Business Overview
Table 87. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product
Table 88. Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 89. Celltrion Biocon Recent Development
Table 90. Hospira Company Details
Table 91. Hospira Business Overview
Table 92. Hospira Bio Similars/Subsequent Entry Biologic Product
Table 93. Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 94. Hospira Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Bio Similars/Subsequent Entry Biologic Product
Table 98. Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Biogen idec Company Details
Table 101. Biogen idec Business Overview
Table 102. Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 103. Biogen idec Recent Development
Table 104. Genentech (Roche) Company Details
Table 105. Genentech (Roche) Business Overview
Table 106. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product
Table 107. Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 108. Genentech (Roche) Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Bio Similars/Subsequent Entry Biologic Product
Table 112. Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 113. Pfizer Recent Development
Table 114. Celltrion Company Details
Table 115. Celltrion Business Overview
Table 116. Celltrion Bio Similars/Subsequent Entry Biologic Product
Table 117. Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 118. Celltrion Recent Development
Table 119. Biocon Company Details
Table 120. Biocon Business Overview
Table 121. Biocon Bio Similars/Subsequent Entry Biologic Product
Table 122. Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 123. Biocon Recent Development
Table 124. Amgen Company Details
Table 125. Amgen Business Overview
Table 126. Amgen Bio Similars/Subsequent Entry Biologic Product
Table 127. Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 128. Amgen Recent Development
Table 129. Samsung Biologics Company Details
Table 130. Samsung Biologics Business Overview
Table 131. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product
Table 132. Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 133. Samsung Biologics Recent Development
Table 134. Mylan Company Details
Table 135. Mylan Business Overview
Table 136. Mylan Bio Similars/Subsequent Entry Biologic Product
Table 137. Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 138. Mylan Recent Development
Table 139. Dr. Reddy's Laboratories Company Details
Table 140. Dr. Reddy's Laboratories Business Overview
Table 141. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product
Table 142. Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 143. Dr. Reddy's Laboratories Recent Development
Table 144. Stada Arzneimittel AG Company Details
Table 145. Stada Arzneimittel AG Business Overview
Table 146. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product
Table 147. Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 148. Stada Arzneimittel AG Recent Development
Table 149. AbbVie Company Details
Table 150. AbbVie Business Overview
Table 151. AbbVie Bio Similars/Subsequent Entry Biologic Product
Table 152. AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 153. AbbVie Recent Development
Table 154. Sanofi-Aventis Company Details
Table 155. Sanofi-Aventis Business Overview
Table 156. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product
Table 157. Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 158. Sanofi-Aventis Recent Development
Table 159. Johnson & Johnson Company Details
Table 160. Johnson & Johnson Business Overview
Table 161. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product
Table 162. Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 163. Johnson & Johnson Recent Development
Table 164. Novo Nordisk Company Details
Table 165. Novo Nordisk Business Overview
Table 166. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product
Table 167. Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 168. Novo Nordisk Recent Development
Table 169. Eli Lilly Company Details
Table 170. Eli Lilly Business Overview
Table 171. Eli Lilly Bio Similars/Subsequent Entry Biologic Product
Table 172. Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 173. Eli Lilly Recent Development
Table 174. Novartis Company Details
Table 175. Novartis Business Overview
Table 176. Novartis Bio Similars/Subsequent Entry Biologic Product
Table 177. Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 178. Novartis Recent Development
Table 179. 3sbio Company Details
Table 180. 3sbio Business Overview
Table 181. 3sbio Bio Similars/Subsequent Entry BiologicProduct
Table 182. 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 183. 3sbio Recent Development
Table 184. Biotech Company Details
Table 185. Biotech Business Overview
Table 186. Biotech Bio Similars/Subsequent Entry Biologic Product
Table 187. Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 188. Biotech Recent Development
Table 189. Gelgen Company Details
Table 190. Gelgen Business Overview
Table 191. Gelgen Bio Similars/Subsequent Entry Biologic Product
Table 192. Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 193. Gelgen Recent Development
Table 194. Innovent Company Details
Table 195. Innovent Business Overview
Table 196. Innovent Bio Similars/Subsequent Entry Biologic Product
Table 197. Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 198. Innovent Recent Development
Table 199. Dong Bao Company Details
Table 200. Dong Bao Business Overview
Table 201. Dong Bao Bio Similars/Subsequent Entry Biologic Product
Table 202. Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 203. Dong Bao Recent Development
Table 204. Ganlee Company Details
Table 205. Ganlee Business Overview
Table 206. Ganlee Bio Similars/Subsequent Entry Biologic Product
Table 207. Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2016-2021) & (US$ Million)
Table 208. Ganlee Recent Development
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bio Similars/Subsequent Entry Biologic Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Other Features
Figure 8. Global Bio Similars/Subsequent Entry Biologic Market Share by Application: 2020 VS 2027
Figure 9. Tumor Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Other Case Studies
Figure 14. Bio Similars/Subsequent Entry Biologic Report Years Considered
Figure 15. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Bio Similars/Subsequent Entry Biologic Market Share by Regions: 2020 VS 2027
Figure 18. Global Bio Similars/Subsequent Entry Biologic Market Share by Regions (2022-2027)
Figure 19. Global Bio Similars/Subsequent Entry Biologic Market Share by Players in 2020
Figure 20. Global Top Bio Similars/Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Bio Similars/Subsequent Entry Biologic Revenue in 2020
Figure 22. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2016-2021)
Figure 23. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2022-2027)
Figure 24. North America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Bio Similars/Subsequent Entry Biologic Market Share by Type (2016-2027)
Figure 26. North America Bio Similars/Subsequent Entry Biologic Market Share by Application (2016-2027)
Figure 27. North America Bio Similars/Subsequent Entry Biologic Market Share by Country (2016-2027)
Figure 28. United States Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Bio Similars/Subsequent Entry Biologic Market Share by Type (2016-2027)
Figure 32. Europe Bio Similars/Subsequent Entry Biologic Market Share by Application (2016-2027)
Figure 33. Europe Bio Similars/Subsequent Entry Biologic Market Share by Country (2016-2027)
Figure 34. Germany Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Share by Region (2016-2027)
Figure 44. China Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Bio Similars/Subsequent Entry Biologic Market Share by Type (2016-2027)
Figure 52. Latin America Bio Similars/Subsequent Entry Biologic Market Share by Application (2016-2027)
Figure 53. Latin America Bio Similars/Subsequent Entry Biologic Market Share by Country (2016-2027)
Figure 54. Mexico Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Share by Country (2016-2027)
Figure 60. Turkey Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Sun Pharma Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 64. Synthon Pharmaceuticals Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 66. LG Life Sciences Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 67. Celltrion Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 68. Hospira Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 70. Biogen idec Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 71. Genentech (Roche) Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 72. Pfizer Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 73. Celltrion Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 74. Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 75. Amgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 76. Samsung Biologics Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 77. Mylan Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 78. Dr. Reddy's Laboratories Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 79. Stada Arzneimittel AG Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 80. AbbVie Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 81. Sanofi-Aventis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 82. Johnson & Johnson Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 83. Novo Nordisk Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 84. Eli Lilly Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 85. Novartis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 86. 3sbio Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 87. Biotech Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 88. Gelgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 89. Innovent Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 90. Dong Bao Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 91. Ganlee Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2016-2021)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Keyplayers in Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2021-2027
Sun PharmaSynthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Request Sample
Request Discount
